Please enable JavaScript to continue using this application.

Compare $ELTX vs $HOWL | Chartloom

Compare

$ELTX vs $HOWL

Elicio Therapeutics Inc · Werewolf Therapeutics Inc

ELTX

Elicio Therapeutics Inc

HOWL

Werewolf Therapeutics Inc

Compare $ELTX vs $HOWL

Comparing Elicio Therapeutics Inc and Werewolf Therapeutics Inc

ELTXElicio Therapeutics Inc

HOWLWerewolf Therapeutics Inc

ELTXElicio Therapeutics Inc

Market cap

$44M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-91.9%

YTD performance

-76.5%

52W performance

-82.0%

FCF yield

-86.7%

HOWLWerewolf Therapeutics Inc

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

51.9%

52W performance

-47.9%

FCF yield

-63.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ELTX

HOWL

Detailed metrics comparison

ELTX

Elicio Therapeutics Inc

HOWL

Werewolf Therapeutics Inc

Market Cap

ELTX$44M

HOWL$48M

Enterprise Value

ELTX$30M

HOWL$26M

Price

ELTX$1.89

HOWL$0.98

P/E Ratio

ELTXN/A

HOWLN/A

P/S Ratio

ELTX1.70x

HOWL2.27x

EV/Sales

ELTX0.00x

HOWL1.22x

EV/EBITDA

ELTX0.00x

HOWL0.00x

P/B Ratio

ELTX6.36x

HOWL2.77x

P/FCF Ratio

ELTXN/A

HOWLN/A

EV/FCF

ELTX-0.78x

HOWL-0.85x

PEG Ratio

ELTXN/A

HOWLN/A

Forward P/E (NTM)

ELTXN/A

HOWLN/A

Forward P/S (NTM)

ELTXN/A

HOWLN/A

Revenue (TTM)

ELTX$0

HOWL$21M

Revenue Growth (YoY)

ELTX-91.9%

HOWLN/A

Forward Rev Growth

ELTX152.2%

HOWL0.0%

Gross Margin (TTM)

ELTX98.5%

HOWL0.0%

Operating Margin (TTM)

ELTX0.0%

HOWL18.1%

EBITDA Margin (TTM)

ELTX0.0%

HOWL-104.4%

Net Margin (TTM)

ELTX0.0%

HOWL-164.8%

FCF Margin (TTM)

ELTXN/A

HOWL-143.6%

Net Income (TTM)

ELTX$-38M

HOWL$-35M

FCF (TTM)

ELTX$-38M

HOWL$-30M

EPS (TTM)

ELTX-$1.97

HOWL-$0.71

ROE (TTM)

ELTX-58297.0%

HOWL-16698.0%

ROA (TTM)

ELTX-13994.0%

HOWL-5988.0%

ROIC (TTM)

ELTX-18562.0%

HOWL-8259.0%

Cash

ELTX$23M

HOWL$22M

Debt

ELTX$10M

HOWL$0

Net Cash/Debt

ELTX$14M

HOWL$22M

Current Ratio (TTM)

ELTX2.77x

HOWL2.91x

Quick Ratio (TTM)

ELTX2.55x

HOWL2.80x

Debt/Equity (TTM)

ELTX1.20x

HOWL1.14x

Debt/Assets (TTM)

ELTX0.0%

HOWL0.0%

Interest Coverage (TTM)

ELTXN/A

HOWLN/A

Net Debt/EBITDA (TTM)

ELTX0.00x

HOWL0.00x

Beta

ELTX1.65

HOWL0.57

52W Performance

ELTX-82.0%

HOWL-47.9%

YTD Performance

ELTX-76.5%

HOWL51.9%

% from 52W High

ELTX-88.2%

HOWL-49.4%

% from 52W Low

ELTX10.9%

HOWL262.8%

Asset Turnover (TTM)

ELTX0.33x

HOWL0.87x

FCF Yield (TTM)

ELTX-86.7%

HOWL-63.3%

Earnings Yield (TTM)

ELTX-87.0%

HOWL-72.7%

Dividend Yield (TTM)

ELTXN/A

HOWLN/A

Rule of 40

ELTX-91.9

HOWL-143.6

EV/GP/RG

ELTXN/A

HOWLN/A

Ticker research

View ELTX research View HOWL research

Metric	ELTX Elicio Therapeutics Inc	HOWL Werewolf Therapeutics Inc
Market & Valuation
Market Cap	$44M	$48M
Enterprise Value	$30M	$26M
Price	$1.89	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	2.27x
EV/Sales	0.00x	1.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.36x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-0.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$21M
Revenue Growth (YoY)	-91.9%	N/A
Forward Rev Growth	152.2%	0.0%
Profitability
Gross Margin (TTM)	98.5%	0.0%
Operating Margin (TTM)	0.0%	18.1%
EBITDA Margin (TTM)	0.0%	-104.4%
Net Margin (TTM)	0.0%	-164.8%
FCF Margin (TTM)	N/A	-143.6%
Net Income (TTM)	$-38M	$-35M
FCF (TTM)	$-38M	$-30M
EPS (TTM)	-$1.97	-$0.71
ROE (TTM)	-58297.0%	-16698.0%
ROA (TTM)	-13994.0%	-5988.0%
ROIC (TTM)	-18562.0%	-8259.0%
Financial Health
Cash	$23M	$22M
Debt	$10M	$0
Net Cash/Debt	$14M	$22M
Current Ratio (TTM)	2.77x	2.91x
Quick Ratio (TTM)	2.55x	2.80x
Debt/Equity (TTM)	1.20x	1.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	0.57
52W Performance	-82.0%	-47.9%
YTD Performance	-76.5%	51.9%
% from 52W High	-88.2%	-49.4%
% from 52W Low	10.9%	262.8%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.87x
FCF Yield (TTM)	-86.7%	-63.3%
Earnings Yield (TTM)	-87.0%	-72.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-91.9	-143.6
EV/GP/RG	N/A	N/A
Ticker research	View ELTX research	View HOWL research

Valuation

P/S Ratio

ELTX

1.70x

HOWL

2.27x

EV/FCF

HOWL

-0.85x

ELTX

-0.78x

Growth & revenue

Revenue Growth TTM

ELTX

-91.9%

Forward Revenue Growth

ELTX

152.2%

HOWL

0.0%

Profitability & performance

Gross Margin

ELTX

98.5%

HOWL

0.0%

ROE

HOWL

-16698.0%

ELTX

-58297.0%

FCF Yield %

HOWL

-63.3%

ELTX

-86.7%

52-Week Performance

HOWL

-47.9%

ELTX

-82.0%

Detailed metrics comparison

ELTX

Elicio Therapeutics Inc

HOWL

Werewolf Therapeutics Inc

Market Cap

ELTX$44M

HOWL$48M

Enterprise Value

ELTX$30M

HOWL$26M

Price

ELTX$1.89

HOWL$0.98

P/E Ratio

ELTXN/A

HOWLN/A

P/S Ratio

ELTX1.70x

HOWL2.27x

EV/Sales

ELTX0.00x

HOWL1.22x

EV/EBITDA

ELTX0.00x

HOWL0.00x

P/B Ratio

ELTX6.36x

HOWL2.77x

P/FCF Ratio

ELTXN/A

HOWLN/A

EV/FCF

ELTX-0.78x

HOWL-0.85x

PEG Ratio

ELTXN/A

HOWLN/A

Forward P/E (NTM)

ELTXN/A

HOWLN/A

Forward P/S (NTM)

ELTXN/A

HOWLN/A

Revenue (TTM)

ELTX$0

HOWL$21M

Revenue Growth (YoY)

ELTX-91.9%

HOWLN/A

Forward Rev Growth

ELTX152.2%

HOWL0.0%

Gross Margin (TTM)

ELTX98.5%

HOWL0.0%

Operating Margin (TTM)

ELTX0.0%

HOWL18.1%

EBITDA Margin (TTM)

ELTX0.0%

HOWL-104.4%

Net Margin (TTM)

ELTX0.0%

HOWL-164.8%

FCF Margin (TTM)

ELTXN/A

HOWL-143.6%

Net Income (TTM)

ELTX$-38M

HOWL$-35M

FCF (TTM)

ELTX$-38M

HOWL$-30M

EPS (TTM)

ELTX-$1.97

HOWL-$0.71

ROE (TTM)

ELTX-58297.0%

HOWL-16698.0%

ROA (TTM)

ELTX-13994.0%

HOWL-5988.0%

ROIC (TTM)

ELTX-18562.0%

HOWL-8259.0%

Cash

ELTX$23M

HOWL$22M

Debt

ELTX$10M

HOWL$0

Net Cash/Debt

ELTX$14M

HOWL$22M

Current Ratio (TTM)

ELTX2.77x

HOWL2.91x

Quick Ratio (TTM)

ELTX2.55x

HOWL2.80x

Debt/Equity (TTM)

ELTX1.20x

HOWL1.14x

Debt/Assets (TTM)

ELTX0.0%

HOWL0.0%

Interest Coverage (TTM)

ELTXN/A

HOWLN/A

Net Debt/EBITDA (TTM)

ELTX0.00x

HOWL0.00x

Beta

ELTX1.65

HOWL0.57

52W Performance

ELTX-82.0%

HOWL-47.9%

YTD Performance

ELTX-76.5%

HOWL51.9%

% from 52W High

ELTX-88.2%

HOWL-49.4%

% from 52W Low

ELTX10.9%

HOWL262.8%

Asset Turnover (TTM)

ELTX0.33x

HOWL0.87x

FCF Yield (TTM)

ELTX-86.7%

HOWL-63.3%

Earnings Yield (TTM)

ELTX-87.0%

HOWL-72.7%

Dividend Yield (TTM)

ELTXN/A

HOWLN/A

Rule of 40

ELTX-91.9

HOWL-143.6

EV/GP/RG

ELTXN/A

HOWLN/A

Ticker research

View ELTX research View HOWL research

Metric	ELTX Elicio Therapeutics Inc	HOWL Werewolf Therapeutics Inc
Market & Valuation
Market Cap	$44M	$48M
Enterprise Value	$30M	$26M
Price	$1.89	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	2.27x
EV/Sales	0.00x	1.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	6.36x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-0.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$21M
Revenue Growth (YoY)	-91.9%	N/A
Forward Rev Growth	152.2%	0.0%
Profitability
Gross Margin (TTM)	98.5%	0.0%
Operating Margin (TTM)	0.0%	18.1%
EBITDA Margin (TTM)	0.0%	-104.4%
Net Margin (TTM)	0.0%	-164.8%
FCF Margin (TTM)	N/A	-143.6%
Net Income (TTM)	$-38M	$-35M
FCF (TTM)	$-38M	$-30M
EPS (TTM)	-$1.97	-$0.71
ROE (TTM)	-58297.0%	-16698.0%
ROA (TTM)	-13994.0%	-5988.0%
ROIC (TTM)	-18562.0%	-8259.0%
Financial Health
Cash	$23M	$22M
Debt	$10M	$0
Net Cash/Debt	$14M	$22M
Current Ratio (TTM)	2.77x	2.91x
Quick Ratio (TTM)	2.55x	2.80x
Debt/Equity (TTM)	1.20x	1.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.65	0.57
52W Performance	-82.0%	-47.9%
YTD Performance	-76.5%	51.9%
% from 52W High	-88.2%	-49.4%
% from 52W Low	10.9%	262.8%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.87x
FCF Yield (TTM)	-86.7%	-63.3%
Earnings Yield (TTM)	-87.0%	-72.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-91.9	-143.6
EV/GP/RG	N/A	N/A
Ticker research	View ELTX research	View HOWL research